Peter Salzmann
Algemeen Directeur bij IMMUNOVANT, INC.
Vermogen: 29 M $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Yuval Cohen | M | 49 |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 11 jaar |
| Alan Holmer | M | 74 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 10 jaar |
| Julia G. Butchko | M | 53 | 5 jaar | |
| Atul Pande | M | 69 |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 jaar |
| Robert Discordia | M | 60 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 6 jaar |
| John Jenkins | M | 66 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 6 jaar |
| Jacques Suzanne | F | 53 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 5 jaar |
| George Migausky | M | 69 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 jaar |
| David Hochman | M | 48 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 8 jaar |
| Sean Moran | M | 66 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 10 jaar |
| Avery Catlin | M | 75 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 10 jaar |
| Douglas Hughes | M | 62 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 jaar |
| Marschall Runge | M | 69 | 11 jaar | |
| Yong Ben | M | 50 | 1 jaar | |
| Anne Altmeyer | M | 59 | 2 jaar | |
| Karen Walker | F | 62 | 6 jaar | |
| Eva Barnett | F | 44 | 3 jaar | |
| Mark Levine | M | 51 | 2 jaar | |
| Frank Torti | M | 45 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 jaar |
| William Kaelin | M | 66 | 12 jaar | |
| Katherine Baicker | M | 52 | 13 jaar | |
| Jamere Jackson | M | 54 | 8 jaar | |
| George Golumbeski | M | 67 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 1 jaar |
| Barbara White | M | 73 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | 11 jaar |
| Andrew Fromkin | M | 58 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 jaar |
| Juan Luciano | M | 62 | 8 jaar | |
| Daniel Skovronsky | M | 50 | 6 jaar | |
| Jennifer Moseley | F | - | - | |
| Christina Bertsch | F | - | - | |
| Judy Roth | F | - | - | |
| Maria Alba | M | - | - | |
| Ian Gourley | M | - | - | |
| Sheetal Patel | F | - | - | |
| Andy Deig | M | - | - | |
| Lauren Schrier | F | - | - | |
| Chau Cheng | M | - | - | |
| Michael Elliott | M | - | 4 jaar | |
| Donald Zakrowski | M | - | 12 jaar | |
| Dominic Smethurst | M | 50 | - | |
| Robert Conley | M | - | 7 jaar | |
| Eric Venker | M | 37 | 4 jaar | |
| Jay Stout | M | 61 | 1 jaar | |
| Johna Norton | F | 57 | 7 jaar | |
| William L. Macias | M | 66 | 3 jaar | |
| Ronald DeMattos | M | - | 9 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 100 | 100.00% |
| Bermuda | 5 | 5.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Peter Salzmann
- Persoonlijk netwerk